Endocrinology

Today GEROPHARM is the only one Russian manufacturer of insulin, produced on a full-cycle basis. It can cover 30 % of demand for gene-engineering insulins in the RF

Main / Portfolio / Endocrinology

Own unique technology
Full cycle – from a substance to finished dosage form
Independence from foreign suppliers of raw stock
GEROPHARM insulin substance has been identified* as consistent with the requirements of European and American Pharmacopoeias.
Rinsulin substance is ahead of international standards in terms of degree of purification from impurities
Modern dosage forms: vials, cartridges, pen-injectors

* Independent certified laboratories: Proteome Factory AG Berlin, Prolytic GmbH Frankfurt am Main, Labor L+S AG

RinLis® (insulin lispro)

RinLis® Mix 25 (insulin lispro biphasic 25)

RinGlar® (insulin glargine)

Individual Pen-injector for insulin injections

Creating a reusable pen GEROPHARM pursued the goal to take care of the patients – it was necessary to make a pen-injector maximally convenient for injection of the medicinal product

Rinsulin® means reliable control and safety

Rinsulin® means reliable control and safety

Evodin® (evogliptin)

Medicinal product at the stage of development

Rinformin® long (metformin long)

Medicinal product at the stage of development

Biphasic insulin

Medicinal product at the stage of development

RinFast (insulin aspart)

Medicinal product at the stage of development

Biphasic insulin aspart

Medicinal product at the stage of development

Insulin Degludec

Medicinal product at the stage of development

Evogliptin + Metformin

Medicinal product at the stage of development

Pipeline

Areas of development

Endocrinology

GEROPHARM is developing a full line of insulin bio analogues that are at different stages of studying.

Neurology
Orphan diseases

Neuropsychiatric diseases

Diabetes mellitus

See also

Pharmacovigilance

GEROPHARM pays considerable attention to the regulation of drug safety. The company has the pharmacovigilance system which functions in accordance with the requirements of Russian and international regulatory authorities

Scientific Events

GEROPHARM pays considerable attention to the regulation of drug safety. Currently, the company has the pharmacovigilance system which functions in accordance with international requirements and regulatory requirements for the Russian Federation

Go up